Randomized trials addressing a similar question are commonly published after a trial stopped early for benefit

Journal of Clinical Epidemiology

Volumn 82, Issue , 2017, Pages 12-19

  Murad, M Hassan ^a   Guyatt, Gordon H ^b   Domecq, Juan Pablo ^c,d   Vernooij, Robin W M ^e   Erwin, Patricia J ^a   Meerpohl, Joerg J ^f   Prutsky, Gabriela J ^d,g   Akl, Elie A ^b,h   Mueller, Katharina ⁱ   Bassler, Dirk ^j   Schandelmaier, Stefan ^k   Walter, Stephen D ^b   Busse, Jason W ^l   Kasenda, Benjamin ^k,m   Pagano, Gennaro ⁿ   Pardo Hernandez, Hector ^e   Montori, Victor M ^a   Wang, Zhen ^a   Briel, Matthias ^b,k  

^a MAYO CLINIC   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c HENRY FORD HOSPITAL   (United States)

^d UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^e BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^f UNIVERSITY OF FREIBURG   (Germany)

^g CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^h AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

ⁱ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^j UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^k UNIVERSITY HOSPITAL BASEL   (Switzerland)

^l MCMASTER UNIVERSITY   (Canada)

^m ROYAL MARSDEN HOSPITAL   (United Kingdom)

ⁿ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

more..

Author keywords

Early termination of trials; Methodology; Randomized controlled trials; Systematic review; Trial design; Trials stopped early for benefit

Indexed keywords

ACCURACY; CARDIOLOGY; CONFIDENCE INTERVAL; DATA BASE; EPIDEMIOLOGICAL DATA; FUNDING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; INTENSIVE CARE; LOGISTIC REGRESSION ANALYSIS; MALIGNANT NEOPLASM; MEDICAL RESEARCH; METHODOLOGY; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL BIAS; SYSTEMATIC REVIEW; EARLY TERMINATION OF CLINICAL TRIAL; EPIDEMIOLOGY; FACTUAL DATABASE; PUBLISHING; STATISTICS AND NUMERICAL DATA;

DATABASES, FACTUAL; EARLY TERMINATION OF CLINICAL TRIALS; EPIDEMIOLOGIC STUDIES; HUMANS; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85010282475     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2016.10.006     Document Type: Review

References (20)

1. [1] Zannad, F., Gattis Stough, W., McMurray, J.J., Remme, W.J., Pitt, B., Borer, J.S., et al. When to stop a clinical trial early for benefit: lessons learned and future approaches. Circ Heart Fail 5:2 (2012), 294–302.
2. [2] Montori, V.M., Devereaux, P.J., Adhikari, N.K., Burns, K.E., Eggert, C.H., Briel, M., et al. Randomized trials stopped early for benefit: a systematic review. JAMA 294 (2005), 2203–2209.
3. [3] Bassler, D., Briel, M., Montori, V.M., Lane, M., Glasziou, P., Zhou, Q., et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 303 (2010), 1180–1187.
4. [4] Bassler, D., Ferreira-Gonzalez, I., Briel, M., Cook, D.J., Devereaux, P.J., Heels-Ansdell, D., et al. Systematic reviewers neglect bias that results from trials stopped early for benefit. J Clin Epidemiol 60 (2007), 869–873.
5. [5] Hughes, M.D., Freedman, L.S., Pocock, S.J., The impact of stopping rules on heterogeneity of results in overviews of clinical trials. Biometrics 48 (1992), 41–53.
6. [6] Poldermans, D., Boersma, E., Bax, J.J., Thomson, I.R., van de Ven, L.L., Blankensteijn, J.D., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341 (1999), 1789–1794.
7. [7] Bouri, S., Shun-Shin, M.J., Cole, G.D., Mayet, J., Francis, D.P., Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery. Heart 100 (2014), 456–464 published online July 31, 2013.
8. [8] Prutsky, G.J., Domecq, J.P., Erwin, P.J., Briel, M., Montori, V.M., Akl, E.A., et al. Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design. Trials, 14, 2013, 335.
9. [9] Higgins, J., Green, S., Cochrane Handbook for Systematic Reviews of Interventions In: Collaboration. 2011, TC, Wiley-Blackwell, Hoboken, New Jersey.
10. [10] Van Den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001), 1359–1367.
11. [11] Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P.J., Milants, I., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006), 449–461.
12. [12] Brunkhorst, F.M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358 (2008), 125–139.
13. [13] Arabi, Y.M., Dabbagh, O.C., Tamim, H.M., Al-Shimemeri, A.A., Memish, Z.A., Haddad, S.H., et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 36:12 (2008), 3190–3197.
14. [14] Nice-Sugar Study Investigators, Finfer, S., Chittock, D.R., Li, Y., Foster, D., Dhingra, V., Bellomo, R., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360 (2009), 1283–1297.
15. [15] Walsh, M., Srinathan, S.K., McAuley, D.F., Mrkobrada, M., Levine, O., Ribic, C., et al. The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index. J Clin Epidemiol 67 (2014), 622–628.
16. [16] Pocock, S.J., When to stop a clinical trial. BMJ 305 (1992), 235–240.
17. [17] Reem, A., Schandelmaier, S., Kalu Olu, K., von Niederhäusern, B., Agarwal, A., Frei, R., et al. Premature trial discontinuation often not accurately reflected in registries: comparison of registry records with publications. J Clin Epidemiol, 2016, 10.1016/j.jclinepi.2016.08.011 [Epub ahead of print].
18. [18] Pocock, S.J., When (not) to stop a clinical trial for benefit. JAMA 294 (2005), 2228–2230.
19. [19] Pocock, S.J., Hughes, M.D., Practical problems in interim analyses, with particular regard to estimation. Control Clin Trials 10 (1989), 209S–221S.
20. [20] Zhang, J.J., Blumenthal, G.M., He, K., Tang, S., Cortazar, P., Sridhara, R., Overestimation of the effect size in group sequential trials. Clin Cancer Res 18:18 (2012), 4872–4876.